| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.052 | 23.441 | 24.077 | 28.553 | 33.581 | 19.343 | 0 | 0 | 0 | - |
| Total Income - EUR | 23.052 | 23.441 | 24.078 | 28.555 | 35.605 | 19.417 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 13.877 | 9.375 | 10.906 | 24.277 | 40.653 | 32.946 | 806 | 288 | 85 | - |
| Gross Profit/Loss - EUR | 9.175 | 14.065 | 13.171 | 4.277 | -5.048 | -13.530 | -806 | -288 | -85 | - |
| Net Profit/Loss - EUR | 8.502 | 13.594 | 12.931 | 3.992 | -5.404 | -13.804 | -806 | -288 | -85 | - |
| Employees | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | - |
Check the financial reports for the company - Nelidamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.749 | 2.818 | 2.216 | 2.990 | 3.649 | 1.102 | 599 | 312 | 226 | - |
| Current Assets | 18.178 | 12.578 | 25.957 | 29.312 | 23.464 | 10.774 | 9.845 | 9.876 | 8.000 | - |
| Inventories | 0 | 0 | 0 | 777 | 0 | 800 | 783 | 785 | 0 | - |
| Receivables | 17.904 | 12.104 | 4.582 | 5.160 | 12.237 | 6.137 | 6.169 | 6.188 | 8.000 | - |
| Cash | 274 | 474 | 21.375 | 23.375 | 11.226 | 3.836 | 2.894 | 2.903 | 0 | - |
| Shareholders Funds | 19.903 | 13.648 | 26.348 | 29.856 | 23.873 | 9.617 | 8.598 | 8.336 | 8.226 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 2.025 | 1.748 | 1.825 | 2.447 | 3.240 | 2.259 | 1.846 | 1.852 | 0 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nelidamed Srl